Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina Larter

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 1, 2021
CRISPR/Cas9 System to Knockdown MicroRNA In Vitro and In VivoBin Yi, Kristina Larter, Yaguang Xi
Methods in Molecular Biology (Clifton, N.J.)|August 21, 2021
Genetic Editing of Long Noncoding RNA Using CRISPR/Cas9 TechnologyKristina Larter, Bin Yi, Yaguang Xi
Frontiers in Immunology|October 30, 2023
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancerFokhrul Hossain, Deniz A Ucar, Giulia Monticone, et al.
EMBO Reports|July 15, 2024
Novel immunomodulatory properties of adenosine analogs promote their antiviral activity against SARS-CoV-2Giulia Monticone, Zhi Huang, Peter Hewins, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|April 1, 2021
CRISPR/Cas9 System to Knockdown MicroRNA In Vitro and In VivoBin Yi, Kristina Larter, Yaguang Xi
Methods in Molecular Biology (Clifton, N.J.)|August 21, 2021
Genetic Editing of Long Noncoding RNA Using CRISPR/Cas9 TechnologyKristina Larter, Bin Yi, Yaguang Xi
Frontiers in Immunology|October 30, 2023
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancerFokhrul Hossain, Deniz A Ucar, Giulia Monticone, et al.
EMBO Reports|July 15, 2024
Novel immunomodulatory properties of adenosine analogs promote their antiviral activity against SARS-CoV-2Giulia Monticone, Zhi Huang, Peter Hewins, et al.
Pageof 1